Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Financial Officer

Chief Medical Officer

President and CEO

CFO, Secretary and Treasurer

TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company's drug candidates are TFF Voriconazole Inhalation Powder, which is in Phase II clinical trials for the treatment of invasive pulmonary aspergillosis; and TFF Tacrolimus Inhalation Powder, which is in Phase II clinical trials used to prevent lung transplant rejection. It is also developing other dry powder products, such as Augmenta monoclonal antibodies for the treatment of COVID-19 therapeutics; TFF Niclosamide, which is completed Phase 1 clinical trials for the treatment of COVID-19 disease; and other vaccines. TFF Pharmaceuticals, Inc. has a license agreement with the University of Texas at Austin for the development of inhaled dry powder drugs; a joint development agreement with Augmenta Bioworks, Inc. to develop Augmenta monoclonal antibodies; a licensing and collaboration agreement with UNION therapeutics A/S; and a collaborative research and development agreement with the National Institute of Environmental Health Sciences to develop dry powder formulations of hyaluronan to prevent and treat respiratory diseases. The company was incorporated in 2018 and is headquartered in Fort Worth, Texas.

TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on it...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2023-08-16	Premium	sold	Premium	Premium	Premium	-
2023-08-15	Premium	bought	Premium	Premium	Premium	-
2023-08-15	Premium	bought	Premium	Premium	Premium	Chief Financial Officer
2023-08-15	Premium	bought	Premium	Premium	Premium	-
2023-08-15	Premium	bought	Premium	Premium	Premium	Chief Medical Officer
2023-08-15	Premium	sold	Premium	Premium	Premium	-
2023-08-15	Premium	bought	Premium	Premium	Premium	-
2023-08-15	Premium	bought	Premium	Premium	Premium	President and CEO
2023-03-10	Premium	bought	Premium	Premium	Premium	-
2023-03-10	Premium	bought	Premium	Premium	Premium	President and CEO
2023-03-10	Premium	bought	Premium	Premium	Premium	Chief Financial Officer
2023-03-10	Premium	bought	Premium	Premium	Premium	Chief Medical Officer
2022-12-15	Premium	bought	Premium	Premium	Premium	President and CEO
2022-11-22	Premium	bought	Premium	Premium	Premium	-
2022-05-20	Premium	bought	Premium	Premium	Premium	-
2022-05-18	Premium	bought	Premium	Premium	Premium	-
2022-05-17	Premium	bought	Premium	Premium	Premium	-
2022-05-17	Premium	bought	Premium	Premium	Premium	Chief Financial Officer
2022-05-16	Premium	bought	Premium	Premium	Premium	-
2022-05-16	Premium	bought	Premium	Premium	Premium	President and CEO
2022-05-16	Premium	bought	Premium	Premium	Premium	Chief Financial Officer
2022-05-16	Premium	bought	Premium	Premium	Premium	-
2022-05-16	Premium	bought	Premium	Premium	Premium	-
2022-04-04	Premium	bought	Premium	Premium	Premium	-
2021-09-16	Premium	bought	Premium	Premium	Premium	President and CEO

TFFP - TFF Pharmaceuticals Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for TFFP